Immunohistochemical analysis of retinoic acid receptor-α in human breast tumors. Retinoic acid receptor-α expression correlates with proliferative activity

American Journal of Pathology

Volumn 148, Issue 6, 1996, Pages 1905-1914

  Van Der Leede, Bas Jan M ^a   Geertzema, Jan ^b   Vroom, Thea M ^b   Décimo, Didier ^c   Lutz, Yves ^c   Van Der Saag, Paul T ^a   Van Der Burg, Bart ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; RECEPTOR ANTIBODY; RETINOIC ACID RECEPTOR; RETINOID;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

BREAST NEOPLASMS; CELL DIVISION; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, RETINOIC ACID; TISSUE DISTRIBUTION;

EID: 0029992936     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. De Luca LM: Retinoids, retinoid-responsive genes, cell differentiation, embryogenesis, and neoplasia FASEB J 1991, 5:2924-2932
2. Gudas LJ, Sporn MB, Roberts AB: Cellular biology and biochemistry of the retinoids. The Retinoids: Biology, Chemistry, and Medicine. Edited by MB Sporn, AB Roberts, DS Goodman. New York, Raven Press, 1994, pp 443-520
3. Moon RC, Mehta RG, Rao KVN: Retinoids and cancer in experimental animals. The Retinoids: Biology, Chemistry, and Medicine. Edited by MB Sporn, AB Roberts, DS Goodman. New York, Raven Press, 1994, pp 573-595
4. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980, 605:33-91
5. Amos B, Lotan R: Retinoid-sensitive cells and cell lines. Methods Enzymol 1990, 190:217-225
6. Meng-er H, Yu-Chen Y, Shu-Rong C, Jin-Ren C, JiaXiang L, Long-Jun G, Zhen-Yi W: Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988, 72:567-572
7. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L: All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990, 76:1704-1709
8. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson FN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper S, Strong S: 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986, 315:1501-1505
9. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H: Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990, 323:795-801
10. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueno F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff I: 13-cis-Retinoic acid plus interferon-α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992, 84:241-245
11. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK: 13-cis-Retinoic acid and interferon-α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992, 84:235-240
12. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M Firket P, Rosmentz N, Clerici M, Soresi E, Valente M, Belloni PA, Ravasi G: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993 11:1216-1222
13. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987, 330:444-450
14. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990, 345:224-229
15. Giguère V, Ong ES, Sequi P, Evans R: Identification of a receptor for the morphogen retinoic acid. Nature 1987, 330:624-629
16. de Thé H, Marchio A, Tiollais P, Dejean A: A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 1987, 330:667-670
17. Brand N, Petkovich M, Krust A, Chambon P, de Thé H, Marchio A, Tiollais P, Dejean A: Identification of a second human retinoic acid receptor. Nature 1988, 332: 850-853
18. Krust A, Kastner P, Petkovich M, Zelent A, Chambon P: A third human retinoic acid receptor hRARγ. Proc Natl Acad Sci USA 1989, 86:5310-5314
19. Hamada K, Gleason SL, Levi B-Z, Hirschfeld, S, Appella E, Ozato K: H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen responsive element. Proc Natl Acad Sci USA 1989, 86:8289-8293
20. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM: Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid. Genes Dev 1992, 6:329-344
21. Kastner P, Krust A, Mendelsohn C, Gamier J-M, Zelent A, Leroy P, Staub A, Chambon P: Murine isoforms of retinoic acid receptor y with specific patterns of expression. Proc Natl Acad Sci USA 1990, 87:2700-2704
22. Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier J-M, Kastner P, Dierich A, Chambon P: Multiple isoforms of the mouse retinoic acid receptor a are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991, 10:59-69
23. Zelent A, Mendelsohn C, Kastner P, Krust A, Garnier J-M, Ruffenach F, Leroy P, Chambon P: Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoters and alternative splicing. EMBO J 1991, 10:71-81
24. Gudas LJ: Retinoids: retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ 1992, 3:655-662
25. Leid M, Kastner P, Chambon P: Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 1992, 17:427-433
26. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis-Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992, 68:397-406
27. Levin AA, Sturzenbecker U, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen CI, Rosenberger M, Lovey A, Grippo JF: 9-cis-Retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 1992, 355:359-361
28. Ratko TA, Detrisac CJ, Dinger NM, Thomas CF, Kelloff GJ, Moon RC: Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res 1989, 49:4472-4476
29. Moon RC, Metha RG: Chemoprevention of mammary cancer by retinoids. Basic Life Sci 1990, 52:213-224
30. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB, Sporn MB: Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 1994, 54:4614-4617
31. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 1985, 45:3415-3443
32. Boccardo F, Canobbio L, Resasco M, Decensi AU, Pastorino G, Brema F: Phase II study of tamoxifen, and high-dose retinyl acetate in patients with advanced breast cancer. J Cancer Res Clin Oncol 1990, 116: 503-506
33. Cobleigh MA, Dowlatshahi K, Deutsch TA, Metha RG, Moon RC, Minn F, Benson AB, Rademaker AW, Ashenhurst JB, Wade JL, Welter J: Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer. J Clin Oncol 1993, 11:474-477
34. Costa A, Sacchini V, Decensi A: Retinoids and tamoxifen in breast cancer Chemoprevention. Int J Clin Lab Res 1993, 23:53-55
35. Marth C, Mayer I, Daxenbichler G: Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem Pharmacol 1984, 33:2217-2221
36. r 39,000 protein. Cancer Res 1990, 50:1977-1982
37. van der Burg B, van der Leede BM, Kwakkenbos-Isbrücker L, Salverda S, de Laat SW, van der Saag PT: Retinoic acid resistance of estradiol-independent breast cancer cell lines coincides with diminished expression of functional retinoic acid receptors. Mol Cell Endocrinol 1993, 91:149-157
38. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH Jr: 9-cis-Retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res 1994, 54:6549-6556
39. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RI: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 1992, 52:2236-2242
40. Roman SD, Ormandy CJ, Manning DL, Blarney RW, Nicholson RI, Sutherland RL, Clarke CL: Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 1993, 53:5940-5945
41. van der Leede BM, Folkers GE, van den Brink CE, van der Saag PT, van der Burg B: Retinoic acid receptor α1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol 1995, 109:77-86
42. Sheikh MS, Shao Z-M, Li X-S, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, Rochefort H, Fontana JA: Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-α acquire sensitivity to growth inhibition by retinoids. J Biol Chem 1994, 269:21440-21447
43. Shao Z-M, Sheikh MS, Chen J-C, Kute TE, Aisner S, Schnaper L, Fontana JA: Expression of the retinoic acid nuclear receptors (RARs) and retinoid X receptors (RXR) genes in estrogen receptor positive and negative breast cancer. Int J Oncol 1994, 4:859-863
44. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957, 11:359-377
45. Gaub M-P, Rochette-Egly C, Lutz Y, Ali S, Matthes H, Scheuer I, Chambon P: Immunodetection of multiple species of retinoic acid receptor α: evidence for phosphorylation. Exp Cell Res 1992, 201:335-346
46. Charpin C, Audrac L, Vacheret H, Habib MC, Devictor B, Lavant MN, Toga M: Multiparametric evaluation (SAMBA) of growth fractions (monoclonal Ki-67) in breast carcinoma tissue sections. Cancer Res 1988, 48:4368-4374
47. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL: Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Cancer 1990, 66:1663-1670
48. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R: Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 1990, 50: 7057-7061
49. Rudas M, Gnant MFX, Mittlböck M, Neumayer R, Kummer A, Jakesz R, Reiner G, Reiner A: Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis. Breast Cancer Res Treat 1994, 32:165-175
50. van Gorp J, Weiping L, Jacobse K, Yong-Huei L, Feng-Yuan L, de Weger RA, Li G: Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 1994, 173:81-87
51. de Thé H, Marchio A, Tiollais P, Dejean A: Differential expression and ligand regulation of the retinoic acid receptor α and β. EMBO J 1989, 8:429-433
52. van der Leede BM, van den Brink CE, van der Saag PT: Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol Carcinogen 1993, 8:112-122
53. Chorny JA, Kruse CA, Kleinschmidt-DeMasters BK, Garza-Williams S, Conway DR, Gaub M-P, Rochette-Egly C, Franklin WA: Immunohistochemical study of the retinoic acid receptor a in normal versus neoplastic human tissues. Appl Immunohistochem 1995, 3:64-71
54. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization, and transcription properties of two classes of retinoic acid receptor a fusion proteins in acute leukocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J 1992, 11:629-642
55. Gerdes J, Lelle RJ, Pickartz H, Heidenreich W, Schwarting R, Kurtsiefer L, Stauch G, Stein H: Growth fractions in breast cancers determined in situ with monoclonal antibody Ki67. J Clin Pathol 1986, 9:977-980
56. Potischman N, McCulloch CE, Byers T, Nemoto T, Stubbe N, Milch R, Parker R, Rasmussen KM, Root M, Graham S, Campbell TC: Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Clin Nutr 1990, 52:909-915
57. 3 or antiestrogen to inhibit human breast cancer cell proliferation. J Steroid Biochem Mol Biol 1991, 39:455-460